Jason Campagna

Jason Campagna, Chief Medical Officer of Q32 Bio, has more than 15 years of leadership experience with a focus on advancing clinical development and pipeline efforts at leading biopharmaceutical companies. He was most recently Chief Medical Officer at Intercept Pharmaceuticals, where he oversaw the clinical development of a novel pipeline of therapeutics to treat progressive non-viral liver diseases. Before joining Intercept, Jason held a number of roles of increasing responsibility at The Medicines Company, including most recently Senior Vice President and Health Science Lead of Surgery and Perioperative Care. Prior to transitioning to the biopharmaceutical industry, Jason served as the Chief Medical Quality Officer at Cottage Health System and, prior to this, held faculty appointments at the University of Pennsylvania and Massachusetts General Hospital. Jason received his M.D. and a Ph.D. in Molecular and Cellular Pharmacology, as well as his bachelor’s degree, from the University of Miami. He completed his post-graduate training at Harvard Medical School and Massachusetts General Hospital.